Coeptis Therapeutics Holdings, Inc. financial data

Symbol
COEP, COEPW on Nasdaq
Location
Wexford, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 89% % 96%
Debt-to-equity 74% % -83%
Return On Equity -186% % 83%
Return On Assets -112% % 48%
Operating Margin -2638% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,340,111 shares -87%
Common Stock, Shares, Outstanding 5,157,611 shares -87%
Entity Public Float $8,455,735 USD -71%
Common Stock, Value, Issued $516 USD -87%
Weighted Average Number of Shares Outstanding, Basic 4,745,089 shares -88%
Weighted Average Number of Shares Outstanding, Diluted 4,745,089 shares -88%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $500,996 USD
Cost of Revenue $135,468 USD
Research and Development Expense $1,308,125 USD -56%
Selling and Marketing Expense $106,500 USD
General and Administrative Expense $1,358,180 USD 70%
Operating Income (Loss) $13,217,440 USD -17%
Nonoperating Income (Expense) $448,615 USD -24%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $13,666,055 USD -18%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $13,666,055 USD -18%
Earnings Per Share, Basic -8 USD/shares 48%
Earnings Per Share, Diluted -8 USD/shares 48%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current $421,698 USD
Accounts Receivable, after Allowance for Credit Loss, Current $82,500 USD
Assets, Current $5,990,862 USD 339%
Property, Plant and Equipment, Net $10,020 USD -6.1%
Operating Lease, Right-of-Use Asset $29,104 USD -58%
Intangible Assets, Net (Excluding Goodwill) $406,406 USD
Assets $14,181,641 USD 58%
Accounts Payable, Current $783,103 USD -31%
Accrued Liabilities, Current $210,892 USD -72%
Liabilities, Current $2,705,364 USD -21%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $3,264,864 USD -18%
Retained Earnings (Accumulated Deficit) $108,375,858 USD -14%
Stockholders' Equity Attributable to Parent $10,365,582 USD 115%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $10,916,777 USD 119%
Liabilities and Equity $14,181,641 USD 58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,366,167 USD -24%
Net Cash Provided by (Used in) Financing Activities $6,101,650 USD 291%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 150,000,000 shares
Common Stock, Shares, Issued 5,157,611 shares -87%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,908,487 USD 332%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,193 USD 0%
Deferred Tax Assets, Valuation Allowance $25,591,469 USD 11%
Deferred Tax Assets, Gross $25,591,469 USD 11%
Operating Lease, Liability $29,865 USD -58%
Lessee, Operating Lease, Liability, to be Paid $30,882 USD -60%
Property, Plant and Equipment, Gross $25,237 USD 0%
Operating Lease, Liability, Current $29,865 USD 202%
Lessee, Operating Lease, Liability, to be Paid, Year Two $19,301 USD -58%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,581 USD 1.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,017 USD -82%
Lessee, Operating Lease, Liability, to be Paid, Year Three $19,301 USD
Deferred Tax Assets, Operating Loss Carryforwards $24,971,010 USD 11%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $120,841,292 USD 18%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets $250,000 USD 0%
Depreciation, Depletion and Amortization $295,303 USD 18%
Interest Expense $300,193 USD 74%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%